{
  "created_at": "Sat Jun 25 15:55:36 +0000 2022",
  "id_str": "1540699611534434304",
  "full_text": "Pfizer-BioNTech vaccines modified to target Omicron produced stronger immune responses in study subjects than the original Covid-19 shot, the companies say https://t.co/bfSB7ZvOiU",
  "display_text_range": [
    0,
    179
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/bfSB7ZvOiU",
        "expanded_url": "https://on.wsj.com/3bupHqL",
        "display_url": "on.wsj.com/3bupHqL",
        "indices": [
          156,
          179
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 31,
  "favorite_count": 94,
  "possibly_sensitive": false,
  "original_created_at": "Sat Jun 25 14:13:06 +0000 2022",
  "localize": [
    {
      "locale": "ja",
      "full_text": "オミクロンを標的として改良されたファイザー・バイオテック社のワクチンは、オリジナルのCovid-19注射よりも試験対象者に強い免疫反応を示したと両社は述べている https://t.co/bfSB7ZvOiU 。"
    },
    {
      "locale": "zh",
      "full_text": "辉瑞-生物技术公司表示，针对Omicron修改的疫苗在研究对象中产生的免疫反应比原来的Covid-19针更强，https://t.co/bfSB7ZvOiU。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "輝瑞-生物技術公司表示，針對Omicron修改的疫苗在研究對象中產生的免疫反應比原來的Covid-19針更強，https://t.co/bfSB7ZvOiU。"
    }
  ]
}